UnknownNot applicableNCT05096650

Platelet Rich Plasma for Treatment of Facial Photoaging: A Double-blind, Randomized, Split-face Study

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chang Gung Memorial Hospital
Principal Investigator
Yau-Li Huang, MD
Chang Gung Memorial Hospital, Taipei, Taiwan
Intervention
mesotherapy of platelet rich plasma and platelet poor plasma(procedure)
Enrollment
15 target
Eligibility
20 years · All sexes
Timeline
20212022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05096650 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials